A look back at patients receiving radiosurgery for non-small cell lung cancer brain metastases reports KRAS mutation status is not associated with worse intracranial control, while lower biologically effective dose (BED₁₀ ≥48 Gy) was, supporting standard high-dose radiosurgery regardless of KRAS-status. | Karim, Adv Radiat Oncol 2026
